XLP1 is a condition with numerous and diverse clinical effects, such as deadly hemophagocytic lymphohistiocytosis (HLH), which is primarily caused by the Epstein-Barr virus, lymphomas, an inability to produce enough antibodies, and less common effects of immune dysregulation.